相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis
A. F. Marques et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Invasive fungal infections: a review of epidemiology and management options
D. A. Enoch et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
A fungicidal monoclonal antibody protects against murine invasive candidiasis
MJ Sevilla et al.
INFECTION AND IMMUNITY (2006)
The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis
AS Ibrahim et al.
INFECTION AND IMMUNITY (2006)
Activity of novel non-amphipathic cationic antimicrobial peptides against Candida species
LL Burrows et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis
Q Zhou et al.
INFECTION AND IMMUNITY (2006)
Candidacidal activity of a monoclonal antibody that binds with glycosyl moieties of proteins of Candida albicans
A Kavishwar et al.
MEDICAL MYCOLOGY (2006)
Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium
WS Jang et al.
FEBS LETTERS (2006)
Polysaccharide-containing conjugate vaccines for fungal diseases
A Casadevall et al.
TRENDS IN MOLECULAR MEDICINE (2006)
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Nystatin induces secretion of interleukin (IL)-1β, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism
RR Razonable et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1
M Viejo-Díaz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans
J Rivera et al.
JOURNAL OF IMMUNOLOGY (2005)
Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection
DM Lindell et al.
JOURNAL OF IMMUNOLOGY (2005)
The immune response to fungal infections
S Shoham et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Immunomodulatory activities of small host defense peptides
DME Bowdish et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Immunity to Aspergillus fumigatus:: the basis for immunotherapy and vaccination
S Bellocchio et al.
MEDICAL MYCOLOGY (2005)
Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2
RR Razonable et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
RA Larsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis
AK Chaturvedi et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Dendritic cell-based vaccination against opportunistic fungi
S Bozza et al.
VACCINE (2004)
Recombinant antibodies: a natural partner in combinatorial antifungal therapy
RC Matthews et al.
VACCINE (2004)
Guidelines for treatment of candidiasis
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2004)
Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles
RW Maitta et al.
INFECTION AND IMMUNITY (2004)
Cathelicidins, multifunctional peptides of the innate immunity
M Zanetti
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Fusion proteins comprising a Fusarium-specific antibody linked to antifungal peptides protect plants against a fungal pathogen
D Peschen et al.
NATURE BIOTECHNOLOGY (2004)
A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages
L Nimrichter et al.
MICROBES AND INFECTION (2004)
Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
V Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cutting edge:: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo
JCE Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
S Bozza et al.
BLOOD (2003)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism
K Sau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C-albicans activities
MD Moragues et al.
INFECTION AND IMMUNITY (2003)
Opportunistic mycelial fungal infections in organ transplant recipients:: Emerging importance of non-Aspergillus mycelial fungi
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2003)
Uptake and antifungal activity of oligonucleotides in Candida albicans
MD Disney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies
TD Thullen et al.
INFECTION AND IMMUNITY (2003)
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis
L Polonelli et al.
INFECTION AND IMMUNITY (2003)
Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis
DD Grosso et al.
INFECTION AND IMMUNITY (2003)
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies
H Hebart et al.
BLOOD (2002)
Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants
S Bozza et al.
MICROBES AND INFECTION (2002)
Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid
DG Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance
M Wüthrich et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Diminished primary and secondary influenza virus-specific CD8+ T-cell responses in CD4-depleted Ig-/- mice
JM Riberdy et al.
JOURNAL OF VIROLOGY (2000)
T cell vaccination in mice with invasive pulmonary aspergillosis
E Cenci et al.
JOURNAL OF IMMUNOLOGY (2000)
Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice
E Svirshchevskaya et al.
PEPTIDES (2000)
Cloning of porcine NRAMP1 and its induction by lipopolysaccharide, tumor necrosis factor alpha, and interleukin-1 beta: Role of CD14 and mitogen-activated protein kinases
GL Zhang et al.
INFECTION AND IMMUNITY (2000)
分享论文
